TITLE

Can Aquaporin-1 and Adipophilin in Urine Distinguish Between Malignant and Nonmalignant Renal Lesions?

AUTHOR(S)
Kramer, Mario W.; Merseburger, Axel S.; Tezval, Hossein
PUB. DATE
August 2010
SOURCE
Mayo Clinic Proceedings;Aug2010, Vol. 85 Issue 8, p768
SOURCE TYPE
Academic Journal
DOC. TYPE
Letter
ABSTRACT
A letter to the editor and a reply to the article about the 2 novel urinary biomarkers adipophilin (ADFP) and aquaporin-1 (AQP1) for kidney cancers is presented.
ACCESSION #
52889938

 

Related Articles

  • The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts. Yilmaz, Yusuf // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p782 

    A letter to the editor is presented in response to the article "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH," by Y. Kimura,...

  • Reply to the letter by I. Tasci regarding ‘Clinical usefulness of AGEs as a biomarker for the attenuation of NASH’. Hyogo, Hideyuki // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p781 

    A response by Hideyuki Hyogo and colleagues to a letter to the editor about their article "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the...

  • Reply to the letter by Y. Yilmaz regarding ‘‘the AGEs–RAGE axis and nonalcoholic steatohepatitis’’. Hyogo, Hideyuki // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p784 

    A response by Hideyuki Hyogo and colleagues to a letter to the editor about their article "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the...

  • Clinical usefulness of AGEs as a biomarker for the attenuation of NASH. Tasci, Ilker // Journal of Gastroenterology;Jul2010, Vol. 45 Issue 7, p779 

    A letter to the editor is presented in response to the article "Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH," by Y. Kimura,...

  • Biomarkers for Detecting Thiamine Deficiency—Improving Confidence and Taking a Comprehensive History Are Also Important. Immadisetty, Vyasa; Cant, Thomas; Thyarappa, Praveen; Lingford-Hughes, Anne; Vernon, Jenni // Alcohol & Alcoholism;Nov/Dec2009, Vol. 44 Issue 6, p634 

    A letter to the editor is presented in response to an article on biomarkers that may be employed in the detection of thiamine deficiency published in the previous issue.

  • Biomarkers for Prediction of Cardiovascular Events. Musunuru, Kiran; Blumenthal, Roger S. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1472 

    The article presents a letter to the editor in response to the article "Multiple biomarkers for the prediction of first major cardiovascular events and death," by T. J. Wang and colleagues in the December 21, 2006 issue.

  • Biomarkers for Prediction of Cardiovascular Events. Ridker, Paul M.; Cook, Nancy R. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1472 

    The article presents a letter to the editor in response to the article "Multiple biomarkers for the prediction of first major cardiovascular events and death," by T. J. Wang and colleagues in the December 21, 2006 issue.

  • Biomarkers for Prediction of Cardiovascular Events. Becker, Diane M.; Mora, Samia; Goff Jr., David C. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1473 

    The article presents a letter to the editor in response to the article "Multiple biomarkers for the prediction of first major cardiovascular events and death," by T. J. Wang and colleagues in the December 21, 2006 issue.

  • Biomarkers for Prediction of Cardiovascular Events. Wang, Thomas J.; Larson, Martin G.; Vasan, Ramachandran S. // New England Journal of Medicine;4/5/2007, Vol. 356 Issue 14, p1474 

    The article presents a response by Thomas J. Wang, Martin G. Larson, and Ramachandran S. Vasan to letters to the editor about their article "Multiple biomarkers for the prediction of first major cardiovascular events and death," in the December 21, 2006 issue.

  • Prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes. Fazel, R.; Fang, J.; Kline-Rogers, E.; Smith, D. E.; Eagle, K. A.; Mukherjee, D. // Heart;Mar2005, Vol. 91 Issue 3, p388 

    Presents a letter to the editor related to prognostic value of elevated biomarkers in diabetic and non-diabetic patients admitted for acute coronary syndromes.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics